UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

 

 

 

XBiotech Inc.

(Name of Issuer)

 

 

Common stock, no par value per share

(Title of Class of Securities)

 

 

98400H102

(CUSIP Number)

 

 

15 July 2021

(Date of Event Which Requires Filing of this Statement)

 

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

x Rule 13d-1(b)

 

¨ Rule 13d-1(c)

 

¨ Rule 13d-1(d)

 

*       The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 98400H102

 

1

Name of Reporting Person:

 

Lombard International Assurance S.A. 

 

2

Check the Appropriate Box if a Member of a Group (see instructions)

(a)     ¨     (b)     x

 

3

SEC Use Only

 

4

Citizenship or Place of Organization

 

Luxembourg 

Number
of
Shares
Beneficially
Owned
by
Each
Reporting
Person
With :
5

Sole Voting Power

 

2,103,109  

6

Shared Voting Power

 

None  

7

Sole Dispositive Power

 

2,103,109  

8

Shared Dispositive Power

 

None  

9

Aggregate Amount Beneficially Owned by Each Reporting Person

 

2,103,109 

10

 

Check if the Aggregate Amount in Row (9) Excludes Certain Shares ¨

11

 

Percent of Class Represented by Amount in Row (9)

 

6.92% 

12

 

Type of Reporting Person

 

FI 

 

 

 

 

Item 1(a). Name of Issuer.

 

XBiotech Inc. (the "Issuer").

 

Item 1(b). Address of Issuer's Principal Executive Offices.

 

8201 E. Riverside Dr Bldg. 4, Ste. 100

 

Austin, TX 78744

 

Item 2(a). Names of Persons Filing.

 

This Schedule 13G is filed on behalf of Lombard International Assurance S.A.

 

Item 2(b). Address or Principal Business Office or, if none, Residence.

 

Lombard International Assurance S.A.

4, rue Lou Hemmer

L-1748 Luxembourg

Luxembourg

 

Item 2(c). Citizenship.

 

Luxembourg

 

Item 2(d). Title of Class of Securities.

 

Common Stock

 

Item 2(e). CUSIP Number.

 

98400H102

 

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-3(b) or (c), check whether the person filing is a:

 

    ¨ Not Applicable
  (a) ¨ Broker or dealer registered under section 15 of the Act;
  (b) ¨ Bank as defined in section 3(a)(6) of the Act;
  (c) ¨ Insurance company as defined in section 3(a)(19) of the Act;
  (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940;
  (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
  (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
  (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
  (h)  ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
  (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
  (j) x A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
  (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

 

 

 

 

Item 4. Ownership:

 

(a) Amount beneficially owned:

 

2,103,109 shares

 

(b) Percent of class:

 

6.92%

 

 

(c)Number of shares as to which the person has:

 

(i) Sole power to vote or to direct the vote

 

2,103,109

 

(ii) Shared power to vote or to direct the vote

 

None

 

(iii) Sole power to dispose or to direct the vote

 

2,103,109

 

(iv) Shared power to dispose or to direct the disposition of

 

None

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ¨

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.  

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group.

 

Not applicable

 

Item 9. Notice of Dissolution of Group.

 

Not applicable.

 

Item 10. Certifications.

 

Not applicable.

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: 10 January 2022 Lombard International Assurance S.A.
     
    /s/ Thierry Leung
    Thierry Leung – Head of Fund Administration
     
    /s/ Andreas E. Meier
    Andreas Meier – Chief Investment Officer Europe

 

 

 

XBiotech (NASDAQ:XBIT)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more XBiotech Charts.
XBiotech (NASDAQ:XBIT)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more XBiotech Charts.